Resonance Health (ASX:RHT) is progressing a study that will assist in the collection of evidence to support the roll out of its ‘HepaFat-Scan’ for measuring the volume of fat in liver tissue.
Showing 25 of 2494
Anteo Diagnostics (ASX:ADO) is trading up 7.8% intra-day to $0.041 as it continues to advance patents to strengthen the intellectual property surrounding applying Anteo technology to medical devices.
Adherium (ASX:ADR) has been acknowledged by the UK’s National Institute for Health and Care Excellence (NICE) for its role in improving adherence to asthma medication.
Living Cell Technologies’ (ASX:LCT) patent application related to choroid plexus cells has been published by the U.S. patent office.
Orthocell (ASX:OCC) has been granted a trading halt by the ASX, with its shares placed in pre-open.
ResApp Health (ASX:RAP) has entered into a two-year expanded research collaboration with Massachusetts General Hospital (MGH) in Boston, U.S.
MedAdvisor (ASX:MDR) has acquired the assets of OzDocsOnline, an Australian online doctor-patient communication platform for a total cash consideration of $150,000.
Microbiome company Immuron (ASX:IMC) is witnessing a series of high-value licensing merger & acquisition (LM&A) deals related to NASH (non-alcoholic steatohepatitis) assets.
MGC Pharmaceuticals (ASX:MXC) has received approval in Europe for its cannabidiol based dermatological products for the relief of acne, psoriasis and seborrhoea skin conditions.
Zelda Therapeutics (ASX:ZLD) have been a strong performer on the Australian Securities Exchange in recent months, gaining 60% to $0.04 since listing on the 22 November 2016.
Holista CollTech (ASX:HCT) has collaborated with 2017 Nobel Prize nominee Daryl Thompson to file a patent for the world’s first low glycemic index (GI) sugar made out of all-natural ingredients.
Uscom (ASX:UCM) has manufactured a record number of cardiovascular devices for the month of December 2016 and for 1H FY2017 to meet orders into Chinese, European and U.S. clinical markets.
Actinogen Medical (ASX:ACW) has been granted a trading halt by the ASX, with its shares placed in pre-open.
Proteomics International Laboratories (ASX:PIQ) has raised $574,500 at $0.24 per share via a share purchase plan to existing shareholders.
Regeneus (ASX:RGS) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open.
Living Cell Technologies (ASX:LCT) has completed treatment of all six patients in group 2 of the Phase 2b clinical trial of NTCELL for Parkinson’s disease, at Auckland City Hospital.
Medibio (ASX:MEB) has demonstrated significant diagnostic accuracy in the pilot phase of its U.S. study for delineating individuals with major depressive disorder (MDD) from non-depressed individuals.
Zelda Therapeutics (ASX:ZLD) has entered into a research collaboration agreement with Curtin University, which expands the company's pre-clinical cancer activities to include pancreatic cancer.
MOD Resources (ASX:MOD) has successfully raised about $5.46 million from an institutional placement to accelerate the development of the T3 Project in the Kalahari Copper Belt, Botswana.
Optiscan Imaging's (ASX:OIL) shares have been climbing recently, last trading at $0.051, or close to double their value from four-months earlier.
Ellex Medical Lasers (ASX:ELX) has commenced clinical training of physicians in China in the use of the Ellex iTrack™ minimally invasive glaucoma surgery (MIGS) device.
MOD Resources (ASX:MOD) has been granted a trading halt by the ASX, pending details of a capital raising.
Cynata Therapeutics (ASX:CYP) has received approval from the National Health Service (NHS), England for the Phase 1 trial in patients with steroid-resistant acute GvHD (graft versus host disease).
ResApp Health (ASX:RAP) has initiated a study in the U.S. to evaluate the efficacy of the ResAppDx app for the diagnosis of childhood pneumonia and other respiratory conditions.
MOD Resources (ASX:MOD) has been granted a two-year extension for its joint venture licences centred around the company’s T3 Project in the Kalahari Copper Belt, Botswana.